| Primary role of criteria |
Cardoso [9] |
Friedman et al [8] |
Inclusion in current study |
| Risk for device-related infections |
Received invasive procedures in the 30 days before the infection, including specialized nursing care |
Received intravenous therapy at home; received wound care or specialized nursing care through a health care agency, family, or friends; or had self-administered intravenous medical therapy in the 30 days before the bloodstream infection. Patients whose only home therapy was oxygen use were excluded. |
No examples in current study |
| Risk for device-related infections and colonization with resistant organisms |
Attended a hospital or hemodialysis clinic in the previous 30 days; |
Attended a hospital or hemodialysis clinic or received intravenous chemotherapy in the 30 days before the bloodstream infection. |
These criteria were included |
| Colonization with resistant organisms |
Were hospitalized in an acute care hospital for 2 or more days in the previous year; |
Was hospitalized in an acute care hospital for 2 or more days in the 90 days before the bloodstream infection. |
Yes, the 90-day cutoff is more applicable in the absence of evaluating for prolonged carriage of resistant organisms |
| Colonization with resistant organisms |
Resided in a nursing home or long-term care facility; |
Resided in a nursing home or long-term care facility. |
No examples in current study (nursing homes are rare in this setting) |
| Colonization with resistant organisms |
Treatment with broad spectrum antibiotics in the last 30 days. |
|
This was not included since the information was usually missing and because this criterion is relevant for resistant organisms rather than SAB |
| Systemic infection due to skin breakdown |
|
|
Widespread skin breakdown secondary to drug treatment. This is supported by the significant number of patients with SAB associated with skin breakdown |
